Submucous myomas treated with gonadotropin releasing hormone agonist and resulting in vaginal hemorrhage. A case report.
Gonadotropin releasing hormone agonists are often used in the management of myomas in an attempt to decrease both the myoma and uterine volume. This therapy in a woman with submucous myomas resulted in profuse vaginal bleeding requiring a transfusion and myomectomy.
Thorp
J M
JM
Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill 27599-7570.
Katz
V L
VL
D000328:Adult; D001803:Blood Transfusion; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D016729:Leuprolide / Q000008:administration & dosage / Q000009:adverse effects*; D014592:Uterine Hemorrhage / Q000139:chemically induced* / Q000601:surgery / Q000628:therapy; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D016729:Leuprolide